'Why do children with cerebral palsy discontinue therapy with botulinum toxin A?'.
Linder-Lucht
Michaela
M
Kirschner
Janbernd
J
Herrmann
Jochen
J
Geth
Katrin
K
Korinthenberg
Rudolf
R
Berweck
Steffen
S
Heinen
Florian
F
Mall
Volker
V
D000293:Adolescent; D000906:Antibodies / Q000276:immunology; D019274:Botulinum Toxins, Type A / Q000276:immunology / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000188:drug therapy*; D002648:Child; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D012189:Retrospective Studies; D028761:Withholding Treatment
D000906:Antibodies; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A